Michele Johnson

As the global pharmaceutical supply chain becomes increasingly complex, the pressure to remain resilient and cost-efficient is mounting. From rising geopolitical tensions and shifting trade alliances to escalating tariffs and inflationary costs, pharma leaders are being forced to re-evaluate sourcing strategies, regionalization plans, and risk mitigation frameworks.

In this dynamic closing panel, senior supply chain and policy leaders will discuss:

·        Learn how global instability is shaping pharma’s operational decisions and long-term strategy

·        Discuss what new and proposed tariffs mean for the future of pharmaceutical manufacturing, sourcing, and pricing

·        Discover how companies are rethinking supplier diversification, nearshoring, and inventory strategies to stay ahead of uncertainty